Safety profile and clinical results of Remdesivir in Hemodialysis patients infected with SARS-CoV-2. A single-center Spanish cohort study

J Nephrol. 2023 Jan;36(1):171-172. doi: 10.1007/s40620-022-01364-3. Epub 2022 Jun 18.
No abstract available

Keywords: COVID-19; COVID-19 treatment; Hemodialysis; Remdesivir; SARS-CoV-2.

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / adverse effects
  • COVID-19 Drug Treatment
  • COVID-19*
  • Cohort Studies
  • Humans
  • Renal Dialysis / adverse effects
  • SARS-CoV-2*

Substances

  • remdesivir
  • Antiviral Agents